High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial
在全口服利福平耐药结核病治疗的第一周使用高剂量阿米卡星是安全的:一项单臂试验
期刊:
影响因子:
doi:10.5588/ijtldopen.25.0120
Snobre, J; Gasana, J; Decroo, T; Mucyo, Y; Jacobs, B K M; Rigouts, L; Martin, I C; Herssens, N; Hakizayezu, F; Ntihumbya, J B; Kilibazayire, A; de Viron, E; Runyambo, D; Ndayishimiye, C; Merle, C S; Muvunyi, C M; Migambi, P; Sturkenboom, M G G; de Jong, B C; Ngabonziza, J C S